Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98,567,360
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
24,422,607
-
Shares change
-
+24,196,892
-
Total reported value, excl. options
-
$1,126,537,026
-
Value change
-
+$1,116,076,476
-
Number of buys
-
58
-
Price
-
$46.34
Significant Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q4 2020
60 filings reported holding SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,422,607 shares
of 98,567,360 outstanding shares and own 24.78% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (8,740,887 shares), FMR LLC (3,441,304 shares), EcoR1 Capital, LLC (2,533,635 shares), RA CAPITAL MANAGEMENT, L.P. (1,742,186 shares), BOXER CAPITAL, LLC (1,675,377 shares), Nantahala Capital Management, LLC (1,206,471 shares), Cormorant Asset Management, LP (500,000 shares), AMERIPRISE FINANCIAL INC (428,714 shares), BlackRock Inc. (390,161 shares), and EVENTIDE ASSET MANAGEMENT, LLC (341,473 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.